MannKind

$4.31
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.06 (+1.53%) As of 6:15 PM UTC today

Why Robinhood?

You can buy or sell MannKind and other stocks, options, and ETFs commission-free!

About MNKD

MannKind Corp. operates as a biopharmaceutical company. It focuses on the discovery, development and commercialization of therapeutic products for diseases, such as diabetes and cancer.

CEO
Michael E. Castagna
Employees
241
Headquarters
Westlake Village, California
Founded
1991
Market Cap
1.02B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
5.06M
High Today
$4.37
Low Today
$4.15
Open Price
$4.21
Volume
1.97M
52 Week High
$6.25
52 Week Low
$1.02

MNKD Earnings

-$0.08
-$0.05
-$0.03
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 5, Pre-Market

You May Also Like

ACH
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure